Lord David Prior Appointed as Chair of e-therapeutics’ Board of Directors

JP Jenkins Ltd Lord David Prior Appointed as Chair of e-therapeutics’ Board of Directors 23-May-2024 / 08:32 GMT/BST The issuer is solely responsible for the content of this announcement.

 

23rd May 2024

JPJ:ETX

ISIN: GB00B2823H99

 

 

e-therapeutics plc  

("e-therapeutics" or “ETX” or the "Company") 

 

Lord David Prior Appointed as Chair of e-therapeutics’ Board of Directors

 

 

London, UK, 23 May 2024 – e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, is pleased announce the appointment of Lord David Prior to its Board of Directors. Lord Prior will assume the role of Chair of the Board with immediate effect. Professor Trevor Jones will step down as Chair and will remain a non-executive director of the Company. 

 

Lord Prior brings extensive healthcare experience to e-therapeutics’ Board. He served as Chair of Norfolk and Norwich University Hospitals NHS Foundation Trust from 2002 to 2012, before becoming Chair of the Care Quality Commission. In 2015, he was appointed Parliamentary Under Secretary of State for Health and created a Life Peer. In December 2016, he was appointed as Parliamentary Under Secretary of State at the Department of Business, Energy & Industrial Strategy, with specific responsibility for developing industrial strategy. Lord Prior stepped down from this role in October 2017 to become Chair of University College London Hospitals and subsequently became Chair of NHS England, a Director of Genomics England and a member of the UK Life Sciences Council to March 2022.